Hagen, Germany

Michael Kayser


Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Hagen, DE (1987 - 1992)
  • Leverkusen, DE (1989 - 1994)

Company Filing History:


Years Active: 1987-1994

Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Kayser

Introduction

Michael Kayser is a prominent inventor based in Hagen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of circulation-active compounds. With a total of 17 patents to his name, Kayser's work has had a notable impact on various applications in the pharmaceutical industry.

Latest Patents

Among his latest patents are the "Circulation-active dioxyalkylenearyl-dihydropyridines" and "Circulation active 4-aminoaryldihydropryidine lactones." These innovations focus on specific chemical formulas where R.sup.1 can be hydrogen, CN, NO.sub.2, or other organic radicals. His research continues to push the boundaries of what is possible in medicinal chemistry.

Career Highlights

Michael Kayser has built a successful career at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work has been instrumental in advancing the understanding and application of dihydropyridine compounds. Kayser's dedication to research and innovation has earned him recognition in his field.

Collaborations

Throughout his career, Kayser has collaborated with esteemed colleagues such as Rainer Gross and Matthias Schramm. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research.

Conclusion

Michael Kayser's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing science. His work continues to influence the pharmaceutical industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…